Vitamin e and Evoxac drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vitamin e (tocopherols and tocotrienols) and Evoxac (cevimeline hydrochloride). Common drug interactions include hypertonic bladder among females and blood creatine phosphokinase mb increased among males.

The phase IV clinical study analyzes what interactions people have when they take Vitamin e and Evoxac. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Vitamin e?

Vitamin e has active ingredients of tocopherols and tocotrienols. It is often used in vitamin supplementation. eHealthMe is studying from 42,279 Vitamin e users. Check the latest studies of Vitamin e.

What is Evoxac?

Evoxac has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 2,028 Evoxac users. Check the latest studies of Evoxac.



On Jul, 15, 2026

36 people who take Vitamin e and Evoxac together, and have interactions are studied.

Vitamin e and Evoxac drug interactions.

What are the common drug interactions of Vitamin E and Evoxac, by gender? *:

female:

  1. Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate)
  2. Hypomania (a mild form of mania, marked by elation and hyperactivity)
  3. Ilium fracture
  4. Incontinence (lack of moderation or self-control)
  5. Infection
  6. Fall
  7. Arthralgia (joint pain)
  8. Diarrhoea
  9. Drug ineffective
  10. Fibromyalgia (a long-term condition which causes pain all over the body)

male:

  1. Blood creatine phosphokinase mb increased
  2. Bone disorder
  3. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  4. Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)
  5. Sweating increased (excess sweating)
  6. Burning sensation
  7. Cardiac enzymes increased
  8. Chest pain
  9. Decreased activity
  10. Dizziness (excl vertigo)

What are the common drug interactions of Vitamin E and Evoxac, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Breakthrough pain
  2. Hyperhidrosis (abnormally increased sweating)
  3. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  4. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  5. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  6. Therapeutic response unexpected

40-49:

n/a

50-59:

  1. Flushing (the warm, red condition of human skin)
  2. Headache (pain in head)
  3. Irritable bowel syndrome
  4. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  7. Tenderness (pain or discomfort when an affected area is touched)
  8. Abdominal discomfort
  9. Abdominal pain
  10. Abdominal pain upper

60+:

  1. Fall
  2. Nausea (feeling of having an urge to vomit)
  3. Anxiety
  4. Back pain
  5. Bursa disorder
  6. Depression
  7. Drug ineffective
  8. Fibromyalgia (a long-term condition which causes pain all over the body)
  9. Headache (pain in head)
  10. Inflammation

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 22.22%
  2. Insomnia (sleeplessness): 6 people, 16.67%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 13.89%
  4. Pain: 4 people, 11.11%
  5. Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 11.11%
  6. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 8.33%
  7. Osteoporosis (bones weak and more likely to break): 3 people, 8.33%
  8. Stress And Anxiety: 2 people, 5.56%
  9. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 5.56%
  10. Multiple Myeloma (cancer of the plasma cells): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Vitamin e and Evoxac?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vitamin e and Evoxac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vitamin e:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Evoxac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vitamin e and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Evoxac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tocopherols and tocotrienols and cevimeline hydrochloride (the active ingredients of Vitamin e and Evoxac, respectively), and Vitamin e and Evoxac (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: